Participate in a research study to assess new potential treatments for IPF related cough


You are invited to participate in a research study to help test new treatments for IPF related cough


Study Description

The purpose of this study is to evaluate the efficacy of an investigational study drug for treatment of persistent cough in patients with Idiopathic Pulmonary Fibrosis (IPF) and understand the impact on patients cough symptoms over time.

Do I Qualify?

  • Must live in the United States

  • Must be 40+ Years of Age

  • Have a confirmed diagnosis of IPF from a doctor

  • Be willing to participate in a clinical trial

  • Additional criteria will be assess by study staff

  • Compensation for Participation & Travel will be provided (*subject to qualifying)

Principal Study Investigator

Spartenburg Fogarty.jpg

Charles Fogarty, M.D.

Pulmonologist, Principal Investigator

Spartenburg Medical Research

(888) 550-3078 ext. 101